118 results
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
7 Nov 22
Ligand Reports Third Quarter 2022 Financial Results
4:04pm
antibody discovery business. I am excited for what lies ahead for Ligand and OmniAb as both execute their strategic goals as independent, publicly traded
425
EX-99.1
y54uzpy54eajnur0 dj
23 Mar 22
Business combination disclosure
5:29pm
8-K
EX-99.1
fz9i2 b60c48wkm
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
gdq6tcvnvlnbx1 d6zg
27 Jan 22
Departure of Directors or Certain Officers
4:02pm
8-K
5ii350no 2tuu
28 Jan 21
Entry into a Material Definitive Agreement
4:42pm
8-K
6riagvqr
23 Dec 19
Departure of Directors or Certain Officers
4:06pm